Postmenopausal Hormone Therapy and Changes in Mammographic Density.
From: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publish Date: Apr 2007
- ISSN: 1527-7755
- Volume: 25
- Issue: 11
- Pages: 1323-8
- Medium: Internet
- Language: English
- Citation (JAMA): van Duijnhoven Fränzel J B, Peeters Petra H M, Warren Ruth M L, et al. Postmenopausal Hormone Therapy and Changes in Mammographic Density.. J. Clin. Oncol. Apr 2007;25:1323-8
Abstract
PURPOSE: Hormone therapy (HT) use has been associated with an increased breast cancer risk. We explored the underlying mechanism further by determining the effects of HT on mammographic density, a measure of dense tissue in the breast and a consistent breast cancer risk factor. PATIENTS AND METHODS: A total of 620 HT users and 620 never users from the Dutch Prospect-European Prospective Investigation into Cancer and Nutrition (EPIC) cohort and 175 HT users and 161 never users from the United Kingdom EPIC-Norfolk cohort were included. For HT users, one mammogram before and one mammogram during HT use was included. For never users, mammograms with similar time intervals were included. Mammographic density was assessed using a computer-assisted method. Changes in density were analyzed using linear regression. RESULTS: The median time between mammograms was 3.0 years and the median duration of HT use was 1 year. The absolute mean decline in percent density was larger in never users (7.3%) than in estrogen therapy users (6.4%; P = .22) and combined HT users (3.5%; P < .01). The effect of HT appeared to be high in a small number of women, whereas most women were unaffected. CONCLUSION: Our results suggest that HT use, and especially estrogen and progestin use, slows the changes from dense patterns to more fatty patterns that are normally seen in women with increasing age. Given that it is postulated that lifetime cumulative exposure to high density may be related to breast cancer risk, a delay in density decline in HT users potentially could explain their increased breast cancer risk.
Mesh Headings (Keywords): Aged, Breast, Europe, Female, Hormone Replacement Therapy, Humans, Mammography, Middle Aged, Postmenopause, Questionnaires, Risk Factors
Check for Full Text / PubMed Unique Identifier (PMID): 17312333
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.